
Prevalência de comorbidades autoimunes na neuromielite óptica positiva 4-imunoglobulina G: revisão sistemática e metanálise
NeurologiaResumo original em inglês
O que aconteceu
Autoimmune comorbidities in aquaporin-4-immunoglobulin G (AQP4-IgG)-positive neuromyelitis optica spectrum disorder (NMOSD) may be associated with increased disease severity and therapeutic challenges, yet prevalence estimates vary considerably. Some variability may reflect differences in population characteristics, geography, health systems, and methodology.
To estimate the prevalence of autoimmune comorbidities in AQP4-IgG-positive NMOSD.
We searched MEDLINE, Embase, Cochrane CENTRAL, Global Health, and Global Index Medicus for studies published from inception up to November 13, 2025. Four reviewers independently screened and extracted data in duplicate. Eligible studies were published since 2005 and reported autoimmune comorbidity prevalence among people with AQP4-IgG-positive NMOSD. Pooled proportions with 95% confidence intervals (CIs) were estimated using generalized linear mixed models with random effects. Subgroup analyses examined variation by continent and gross national income classification. We assessed study quality using the Joanna Briggs Institute Critical Appraisal Tool. We assessed publication bias by visually inspecting a funnel plot.
O que encontraram
Seventy studies encompassing 7843 participants were included. The pooled prevalence of at least one autoimmune comorbidity was 22.2% (95% CI, 19.3-25.3, I2 = 78%). Sjögren's syndrome was most frequent (4.6%), followed by systemic lupus erythematosus (SLE) (3.0%) and autoimmune thyroid disease (2.6%). Prevalence varied by region (Europe, 31.1%; North America, 23.9%; South America, 21.9%; Asia, 16.8%) and by income group (high-income, 25.1%; lower-middle-income, 7.0%).
Por que isso importa
Autoimmune comorbidities were frequently documented in AQP4-IgG-positive NMOSD. Estimates should be interpreted cautiously because ascertainment methods were heterogeneous and validated diagnostic criteria were infrequently reported. Regional differences may reflect population, ascertainment, and healthcare-system factors.
Resumo publicado sob licença CC BY. A tradução para o português ainda não chegou a este estudo.
O estudo original
Prevalence of autoimmune comorbidities in aquaporin 4-immunoglobulin G positive neuromyelitis optica spectrum disorder: a systematic review and meta-analysis
Ninglu Weng, Aikjot Randhawa, Karen Sayfee, Anibal Chertcoff, Ruth Ann Marrie, Lucia B Varela
Descritores MeSH
- Aquaporin 4
- Autoimmune Diseases
- Neuromyelitis Optica
- Immunoglobulin G
- Autoantibodies
- Comorbidity
- Prevalence
- Humans
Veja também
Estudos relacionados
- Incidence and Prevalence of Neuromyelitis Optica Spectrum Disorders in the Background of International Consensus Diagnostic Criteria - A Systematic Review
- Uma revisão sistemática e metanálise da eficácia e segurança de eculizumab na neuromielite óptica positiva para AQP4-IgG
- Recomendações para o diagnóstico e tratamento da neuromielite óptica em crianças e adolescentes
- Non-demyelinating disorders mimicking and misdiagnosed as NMOSD: a literature review